Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Clinical Diabetes and Endocrinology|April 24, 2024
Factors associated with high costs of patients with metabolic dysfunction-associated steatotic liver disease: an observational study using the French CONSTANCES cohortArnaud Nze Ossima, Angélique Brzustowski, Valérie Paradis, et al.Ultrasound in Medicine & Biology|July 13, 2025
Multiparametric ultrasound evaluation of metabolic dysfunction-associated fatty liver disease in minipigsGeorges Chabouh, Basile Pradier, Louise Denis, et al.Nature Communications|May 31, 2018
The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesityJulien Bricambert, Marie-Clotilde Alves-Guerra, Pauline Esteves, et al.Hepatology (Baltimore, Md.)|December 17, 2016
Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinomaLucille Morzyglod, Michèle Caüzac, Lucie Popineau, et al.Molecular Metabolism|June 11, 2025
Deletion of PPARα in mouse brown adipocytes increases their De Novo LipogenesisPierre-Louis Batrow, Sylvie Caspar-Bauguil, Nathalie Rochet, et al.Journal of Hepatology|January 22, 2013
Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptorSimon Ducheix, Alexandra Montagner, Arnaud Polizzi, et al.Scientific Reports|April 18, 2020
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesityMarion Régnier, Arnaud Polizzi, Sarra Smati, et al.Cell Reports|April 13, 2022
The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expressionTiffany Fougeray, Arnaud Polizzi, Marion Régnier, et al.Cell Metabolism|October 24, 2025
Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolismJérémy Dufau, Emeline Recazens, Laura Bottin, et al.Diabetes|May 6, 2018
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 DiabetesAmar Abderrahmani, Loïc Yengo, Robert Caiazzo, et al.Pageof 9